After seven days of testimony directly from Elizabeth Holmes, her defense announced it had rested its case this week in a federal fraud trail that began in September.

Holmes, a former Silicon Valley luminary, was CEO of the blood-testing startup Theranos. She told jurors she was not responsible, as prosecutors allege, for fleecing investors of millions of dollars and delivering flawed results to patients.

And as NPR tech reporter Bobby Allyn explains, Holmes detailed a story of abuse that could sway the outcome of the trial.

In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.

Email us at considerthis@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy